Biofarma Holding A/S: Financial statements 2025
CVR: 42243795
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Biofarma Holding A/S (CVR 42243795) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK 10,281,000 compared with DKK 9,891,485 the year before. Equity in the 2025 report amounted to DKK 103,544,000. The solvency ratio was 99.4%.
- Profit/Loss
- DKK 10,281,000
- Equity
- DKK 103,544,000
- Total Assets
- DKK 104,164,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | 10.3 mio. | 103.5 mio. | 0 |
| 2024 | - | - | 9.9 mio. | 93.7 mio. | 1 |
| 2023 | - | 0 | 4.9 mio. | 83.8 mio. | 0 |
| 2022 | 0 | 0 | -515 t. | 77.6 mio. | 0 |
Official annual report
How creditworthy is Biofarma Holding A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Biofarma Holding A/S has published its annual report for 2024. The net result was DKK 9,891,485.
About Biofarma Holding A/S
Biofarma Holding A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Søren Wang Petersen. The board consists of Tyge Jesper Rothe (chair), Niels Christian Assens and Søren Wang Petersen. The company is owned by CAND.PHARM. POVL M. ASSENS FOND. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK 10,281,000 compared with DKK 9,891,485 the year before. Equity in the 2025 report amounted to DKK 103,544,000.